US Hematology Diagnostics Market

Longer Product Cycles Stall Market Growth

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the data for which were collected through an end-user survey. The number of hematology analyzers installed by manufacturer and model were collected from a sample population of more than 4,000 sites. The sample population included hospitals, reference laboratories, and physician’s office laboratories.

Table of Contents

Executive SummaryKey FindingsScope and SegmentationKey Questions This Study Will AnswerMarket Engineering MeasurementsMarket Engineering Measurements (continued)CEO’s PerspectiveKey Companies to WatchExecutive Summary—2 Big PredictionsMarket OverviewMarket SegmentationMarket Segmentation (continued)Customer Segmentation and LandscapeMost Commonly Ordered Hematology TestsDefining Healthcare Trends in the FutureCompetitive PlaybookNew Market OpportunitiesNew Market Opportunities (continued)New Market Opportunities (continued)Merger, Acquisition, and Partnership AssessmentMerger, Acquisition, and Partnership Assessment (continued)Drivers, Restraints, and Trends—Total Hematology Diagnostics MarketMarket DriversMarket RestraintsForecast and Trends—Total Hematology Diagnostics MarketMarket Engineering MeasurementsForecast Assumptions and DefinitionsRevenue ForecastRevenue Forecast DiscussionProcurement ProcessPEST AnalysisCompetitive EnvironmentCompetitive StructureMarket ShareMarket Share AnalysisMarket Share Analysis (continued)Market Share Analysis (continued)Sysmex—Company DashboardBeckman Coulter (Danaher)—Company DashboardAbbott Diagnostics—Company DashboardHoriba ABX—Company DashboardSiemens Healthcare Diagnostics—Company DashboardProduct Analysis Popularity Trend by Model TypePopularity Trend by Model Type (continued)Popularity Trend by Model Type (continued)Popularity Trend by Model Type (continued)Popularity Trend by Model Type (continued)Popular Models—Pricing AnalysisPopular Models—Pricing Analysis (continued)Hematology Analyzers SegmentRevenue ForecastRevenue Forecast DiscussionInstalled Base and Pricing Analysis Hematology Reagents SegmentRevenue ForecastRevenue Forecast DiscussionThe Last WordThe Last Word—2 Big PredictionsThe Last Word—DiscussionThe Last Word—Discussion (continued)Legal DisclaimerAppendixMarket DefinitionsMarket Definitions (continued) Market BackgroundMarket Background (continued) Market Background (continued) Market Background (continued) Hematology Tests and CPT Codes Drivers ExplainedDrivers Explained (continued)Drivers Explained (continued)Restraints ExplainedRestraints Explained (continued)Market Engineering MethodologyAssociated Market Research ServicesLearn More—Next Steps




Related Research

Release Date : 17-Jul-17

Region : North America

Release Date : 13-Sep-16

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.